GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
$Novo-Nordisk A/S(NVO.US)$ $Weight Loss Drugs(LIST2152.US)$ $Eli Lilly and Co(LLY.US)$ $S&P 500 Index(.SPX.US)$ $E-mini NASDAQ 100 Futures(SEP4)(NQmain.US)$ $NVIDIA(NVDA.US)$ $Microsoft(MSFT.US)$ $Meta Platforms(META.US)$
Since its approval in June 2021, the obesity treatment market has undergone a significant transformation. Wegovy, as a GLP-1 medication, has achieved tremendous success. Its effectiveness surpasses that of previously marketed weight-loss drugs, and it is also considered safer.
According to Barclays' predictions, there is still enorm...
Wegovy, which has sparked discussions on social media, is a GLP-1 receptor agonist medication. GLP-1 drugs have now become a goldmine for pharmaceutical giants Novo Nordisk and Eli Lilly, propelling Novo Nordisk to become the most valuable company in Europe, surpassing LVMH Group.
It is said that by sticking to a weekly injection, weight can be...
No comment yet